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CASE REPORT
Desmoid tumours are a rare 
group of locally aggressive, 
non-malignant tumours of 
broblastic origin that can 
result in signicant morbid-
ity due to local invasion and may even result 
in a fatal outcome when located around 
a vital organ. e tumours are known 
to involve muscle, subcutaneous tissue 
and neuromuscular structures, with less 
involvement of the bones.[1]
The abdomen remains the most common 
site of origin of desmoid tumours, which 
can also occur in extra-abdominal areas.[2-5] 
About one-third of all desmoid tumours are 
extra-abdominal, with the majority of these 
occurring in the shoulder girdle or pelvic 
region. The head and neck are an uncommon 
site for these lesions, comprising roughly 11 - 
15% of extra-abdominal desmoids.[6]
We present the case of a 14-month-old 
Rwandan child with a desmoid tumour 
arising on the head in the left mid-face region.
Case report
A 14-month-old child with stertor due 
to an obstructive oral mass and a history 
of progressive facial swelling leading to 
le nasal obstruction was referred to the 
Paediatric Department at Kigali University 
Teaching Hospital, Rwanda. e mass had 
rst been noticed at the corner of the le 
nostril, progressively involving the side of 
the face with nasal deviation and complete 
obstruction over the course of 1 month prior 
to the patient’s arrival in the Department. 
Examination revealed a rm, non-tender 
swelling measuring about 12 cm × 5 cm and 
involving the upper le gingival and so 
palate region with complete obstruction of 
the le nostril (Fig. 1).
On admission, the patient’s general 
status was marked by facial deformity with 
mild respiratory distress. The rest of the 
clinical examination was unremarkable, 
and there was no lymph node involvement. 
The patient received immediate supportive 
care in the form of painkillers and oxygen 
therapy. 
A transcutaneous biopsy of the mass 
was performed and submitted to the 
Department of Pathology at Brigham 
and Women’s Hospital, Boston, USA, for 
histopathological examination. The tumour 
demonstrated histological features of 
aggressive fibro matosis. After histopatho-
logical confirmation of the disease, the 
patient received chemotherapy followed by 
surgical removal of the remnant mass.
The chemotherapy given included a 
combination of vincristine, actinomycin-D 
and cyclophosphamide (VAC). The pre-
operative course was given according to the 
6 weeks schedule: vincristine 2 mg/ m2 in 
intravenous (IV) infusion every 2 weeks, 
actinomycin-D 0.015 mg/kg/d by IV 
infusion for 5 days every 6 weeks, and 
cyclophosphamide 200 mg/m2 during the 
first course for 7 days and during every course 
thereafter for 5 days every 6 weeks. The mass 
had shrunk dramatically after 9 cycles (Fig. 2), 
and excision of the remaining firm mass was 
done when the tumour was resectable.
Pathological examination of the 
resected specimen showed histological 
features identical to the previous biopsy. 
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Desmoid tumours are a rare group of locally aggressive, non-malignant tumours of broblastic origin that can result in signicant morbidity 
due to local invasion. Facial involvement in children with aggressive bromatosis is uncommon. We present the case of a 14-month-old 
Rwandan child with an aggressive desmoid tumour involving the le mid-facial region. e patient presented with severe stertor due to 
massive nasal obstruction. Aer intensive supportive care the diagnosis was conrmed histopathologically. Treatment consisted of eight 
courses of chemotherapy with vincristine, actinomycin-D and cyclophosphamide, followed by surgical removal of the remaining mass. e 
outcome was impressive and encouraging. 
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Fig. 1. Desmoid tumour of the face in a 14-month-
old child. Fig. 2. e response aer 9 cycles of chemotherapy. 
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Postoperatively the patient did well and appears to be free of gross 
disease after the surgical resection.
Discussion
Despite being benign tumours, desmoid bromatosis may aggressively 
invade adjacent structures. ese rare tumours are primarily found 
in the abdominal wall. Lesions of the head and neck representing a 
small subset, of which the majority arise in the supraclavicular region. 
Desmoids of the mid-face, as in our case, are extremely rare. Despite 
advances in the understanding of these tumours, their natural history 
is still not clear and the optimal treatment remains debatable. 
A range of therapeutic options are available, and choosing 
the appropriate method for achieving local control depends on 
the functional and cosmetic outcomes of each method and the 
associated complications. [1] Surgery remains the most favoured 
option when functionally and cosmetically acceptable. Management 
with a combination of modalities is useful in irresectable tumours. 
Radiotherapy may be indicated after margin-positive resection or 
if irresectable large tumours are present with impending functional 
problems in older children. Systemic therapies should also be 
considered when the tumour cannot be resected, especially in cases 
where radiation toxicity may be also unacceptable.
The current trend is strongly in favour of treating asymptomatic 
desmoids with observation, reserving treatment for tumours that may 
pose a threat to vital structures or show continued growth,[1] as in our case.
Conclusion
is is the rst case of aggressive desmoid bromatosis in the mid-
face to be described in a Rwandan child.  Intensive supportive care on 
presentation associated with chemotherapy and surgery contributed 
to the patient’s spectacular clinical response.
Ethics approval. Ethical approval was obtained from Kigali University 
Teaching Hospital, Rwanda, and the patient’s mother consented to the 
publication of the photos. 
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e interesting case of an infant who presented with congenital lymphoedema with features of Milroy disease is presented. e infant’s 
clinical ndings were marked and somewhat atypical. Lymphoscintigraphy demonstrated features consistent with the diagnosis.
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A 6-month-old female infant was brought to Chris 
Hani Baragwanath Academic Hospital, Johannesburg, 
South Africa, in August 2012 by her parents, who 
came from a rural village in Lesotho. According to her 
mother, the baby had been born with a ‘swollen’ body. 
Her face, upper limbs and right leg were most aected. Although the 
swelling had decreased over time, it persisted in the upper limbs and 
right leg. e infant was growing well and had not had any episodes of 
acute illness, and her milestones were appropriate for her age.
Her mother was a primigravida and had had 2 previous miscarriages 
at 1 month and 3 months, respectively. She reported no prenatal 
problems and had given birth vaginally at a rural clinic. e baby 
was born at term with a weight recorded as 3 060 g, and her mother 
reported no postnatal complications. 
Neither of the parents had any illnesses, and there was no history 
of other family members with a similar condition to that of the 
child. There was no history of travel to areas endemic for conditions 
causing lymphoedema.
The baby was active, mobile and curious. Her anthropometry 
was appropriate for her age and she appeared well with no 
dysmorphic features. She had mild peri-orbital oedema and 
striking, non-pitting brawny oedema of the upper limbs and right 
leg (Fig. 1). The oedema was marked at the palm and dorsum 
of the hands and foot with sparing of the distal digits (Fig. 2). 
The oedema of the arms tapered above the level of the biceps. 
The oedema of the limbs was non-tender but firm. There was no 
evidence of lymphadenopathy, ascites or cardiac failure. She had 
no other dermatological stigmata and had full movement of all her 
limbs with good power. 
The primary diagnosis was congenital lymphoedema, consistent 
with features of Milroy disease. This diagnosis was confirmed on 
lymphoscintigraphy, which showed a patent peripheral left lower 
limb lymphatic system and a lack of tracer migration in the right 
lower limb and both upper limbs (Fig. 3).
Discussion
Other dierential diagnoses include lymphoedema-distichiasis 
syndrome, Meige disease, hypotrichosis-lymphedema-telangiectasia 
syndrome, Turner syndrome, Noonan syndrome, and lymphoedema 
with yellow nails/yellow nail syndrome.[1]
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Milroy disease is a congenital form of primary lymphoedema. It is an 
autosomal dominant condition inherited with variable expression and 
reduced penetrance. It is commonly (75% of cases) associated with 
the vascular endothelial growth factor receptor 3 mutation, which 
causes abnormal phosphorylation of a tyrosine kinase reception 
specic for lymphatic vessels.[2,3] is causes lymphatic dysfunction 
leading to lymphoedema.[4]
Milroy disease is more common in females than in males. 
Patients present with firm oedema and the right leg is classically 
the main limb involved, usually below the level of the knee. The 
main morbidity is associated with recurrent bouts of cellulitis and 
lymphangitis. Management is mainly supportive, and no surgical 
method has achieved lasting success.
This case is unusual, as the infant presented with involvement 
of three limbs: the right leg above the level of the knee and both 
arms to the level of the biceps. There was no family history of 
this condition, and it can therefore be assumed that it is either a 
sporadic mutation phenomenon or a case of reduced penetrance 
in a parent.
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Fig. 1. Infant with lymphoedema of both upper limbs and right lower limb 
(reproduced with permission from the parents).
Fig. 2. Right foot, showing typical dorsal oedema (reproduced with permission 
from the parents).
Fig. 3. Lymphoscintigraphy ndings in lower and upper limbs, showing a lack of 
tracer migration in both upper limbs.
